| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2025 | 31 Dec 2024 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Un-audited financial results of the company for the quarter ended December 31 2024 The Board has considered and took on record the Un-audited Financial Results for the quarter ended December 31, 2024 Due to inadvertence, the start & end time of Board meeting was input in Indian time (02:00 To 03:30) instead of international time zone (14:00 To 15:30). The correct date & time of board meeting is as under: Date of board meeting: 14-02-2025 Commencement time: 14:00 hrs End time: 15:30 hrs Due to inadvertence, the start and end time of the Board Meeting held today was input in Indian time (02:00 to 03:30) instead of international time zone (14:00 to 15:30) during the filing of outcome of board meeting under corporate announcements. Correct Start & End time is: Start: 14:00 hrs End: 15:30 hrs (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 14 Nov 2024 | 27 Sep 2024 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Un-Audited Financial results of the company for the quarter and half year ended September 30 2024 Un-audited financial results for the quarter and half year ended September 30, 2024 (As per BSE Announcement dated on 14/11/2024) | ||
| Board Meeting | 13 Aug 2024 | 29 Jun 2024 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended June 30 2024. The Board has considered and took on record the Un-audited Financial Results for the quarter ended June 30, 2024. (As Per BSE Announcement Dated on: 13/08/2024) | ||
| Board Meeting | 23 Jul 2024 | 25 Jul 2024 |
| Appointment of Mr. Manishkumar Indukumar Pipalia and Mr. Sachin Samir Kothary as Non-Executive Independent Directors of the Company for a term of 5 consecutive years each with effect from July 23, 2024, subject to approval of the shareholders at the forthcoming 32nd AGM | ||
| Board Meeting | 30 May 2024 | 28 Mar 2024 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the Audited Standalone Financial Results of the company for the quarter and year ended March 31 2024. The Board of Directors may consider a proposal to recommend dividend on the equity shares of the company for the financial year ended March 31 2024. Final Dividend & Audited Results (As per BSE Bulletin dated on 28/03/2024) The Board of Directors approved and adopted Audited Financial Results for the quarter and year ended March 31, 2024. Recommendation of Dividend @ 10% on paid up capital of the company (As Per BSE Announcement dated on 30.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
